Clinical Trial Update: Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors [NA]

View source ↗

Summary

A Mayo Clinic-sponsored trial evaluating focal laser ablation for low- to intermediate-risk prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Prostate Cancer, Prostate Adenocarcinoma | NA | Status: COMPLETED